News  
  Gästebuch  
  Galerie  
  Augenweide  
  Blumenwerk  
  Forum  
  Webmail  
  Friends  
  Mitglieder  
  Downloads  
  Links  
  Faq  
  Regeln  
kontakt
  Joinus  
  Send a mail  
  Impressum  
  About  
     
 

 

 
     
  Keine Termine gefunden  
     
Forum - Thema
« Vorheriges Thema | Nächstes Thema ->
Forum -> Fahrbares -> Bock, Auto, Fahrrad -> FDA approves Clarus’ Jatenzo as testosterone replacement therapy

Antworten: 0
< [1] >
xysoom


puppenschnitzer



Beiträge 1
# Thema - 07.08.2019 um 19:35 Uhr
FDA approves Clarus’ Jatenzo as testosterone replacement therapy



Clarus Therapeutics has announced that the US Food and Drug Administration (FDA) has approved its oral testosterone undecanoate (TU) Jatenzo for testosterone replacement therapy.

The drug is indicated for a deficiency or absence of endogenous testosterone, such as primary hypogonadism and hypogonadotropic hypogonadism. However, it is not approved for age-related hypogonadal conditions, which are not caused by structural or genetic etiologies.Nolvadex results

Clarus claims it is the first oral testosterone medicine approved in more than 60 years. Oral formulations are seen as superior to current therapies as topic gels bring a risk of transference to women or children and transdermal patches commonly cause application site irritation.

The company is a male health specialist and Jatenzo is its main product. The first-in-class drug contains undecanoate to facilitate the absorption of testosterone through the intestinal lymphatic system. The drug has been formulated so it is less impacted by food after being absorbed.
The FDA’s decision is based upon data from the InTUne clinical trial where Jatenzo was compared to a topical testosterone formulation called Axiron. The study met its primary endpoint with 87% of the Jatenzo group achieved a daily average testosterone level in the normal range. These results were consistent with the other two previous Phase III trials of the drug.

Jatenzo’s safety profile was similar to other testosterone replacement therapies on the market.

Clarus chief executive officer and president Dr Robert Dudley said: “The approval of oral Jatenzo represents a new and significant treatment option for hypogonadal men.

“We believe that an oral testosterone replacement therapy may offer appropriate adult male patients and their physicians the opportunity to reconsider treatment options, and help hypogonadal men find relief from their symptoms.”

Principal investigator of Jatenzo trials, professor of medicine at UCLA David Geffen School of Medicine and Los Angeles Biomedical Research Institute senior scientist Dr Ronald Swerdloff said: “Jatenzo will fill an important void by providing physicians with an oral testosterone formulation FDA has found to be safe and effective to treat adult men with documented hypogonadism associated with structural or genetic etiologies.



Offline
Antworten: 0
< [1] >

Sie müssen sich registrieren, um zu antworten.






 


Cookie setzen


Registrierung
Passwort vergessen


 
 
 
 
Greggreeri: <a href=https://finway.com.ua/ru/ >ПрП бизМес</a>

DannyFreds: http://interior-plan.com/

DonaldSar: XYZ http://xyz.net.tw/

TimothyFuP: ggggg

stanimiralow: <a href=http://top5vergleish.eu/ >http://top5vergleish.eu/</a > drainageance

YuyiCogma: how to write college essay http://story-essay.time4writ ing.dzhumakhanova.site thesis essay

Tavzurbasy: Test. Please ignore.

Traceei: <a href=http://navozmi.ru> </a>

Donalddaf: unethost http://blog.unethost.com/

RavzCypewrep: Test. Please ignore.







Archiv
 
     
  ACHTUNG! Beim Eintragen in die Shoutbox bitte Nick und Code nicht vergessen. ACHTUNG!    

votes

 

 
  Keine Umfrage aktiv  
     
stats
 
  on Online: 32  
yes Gesamt: 855766
today Gestern: 920
monat Monat: 22366
 

 

 

 



Design und bxcp/clansphere anpassung by infiltrate www.clantemplates.at